Header cover image

U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt

UPDATED Oct 01, 2022

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

8 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
PFEPfizerUS$43.76-0.7%1.9%US$245.6bUS$55.75PE8.3xE-16.2%3.7%
MRKMerckUS$86.12-0.8%5.8%US$218.2bUS$100.00PE13.1xE10.2%3.2%
IRWDIronwood PharmaceuticalsUS$10.361.8%-22.3%US$1.6bUS$13.20PE9.2xE9.2%n/a
INVAInnovivaUS$11.61-1.6%-31.8%US$809.3mUS$19.00PE8.1xS-41.4%0%
SELBSelecta BiosciencesUS$1.649.3%-60.8%US$250.4mUS$7.17PE7.9xE-43.1%n/a
PRPHProPhase LabsUS$11.2811.0%119.9%US$180.6mUS$15.00PE6.8xE-53.9%2.7%
SESNSesen BioUS$0.423.6%-45.6%US$84.8mn/aPE1.8xE8.6%n/a
RSCFReflect ScientificUS$0.070%-70.9%US$5.9mn/aPE7.4xn/an/a
Page 1 of 1